AI assistant
Sending…
Vir Biotechnology, Inc. — Director's Dealing 2025
Jun 7, 2025
32538_dirs_2025-06-06_2c36693d-ba0a-4c20-92ef-bf97bd4c5a65.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Vir Biotechnology, Inc. (VIR)
CIK: 0001706431
Period of Report: 2025-06-06
Reporting Person: BISCHOFBERGER NORBERT W (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-06-06 | Common Stock | J | 10667 | — | Disposed | 13333 | Direct |
| 2025-06-06 | Common Stock | J | 10667 | — | Acquired | 10667 | Indirect |
Footnotes
F1: Transfer without consideration for tax planning purposes.
F2: The shares are held in the name of Nextquest, LLC, of which the Reporting Person is a managing member.
More from Vir Biotechnology, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
May 28
Proxy Solicitation & Information Statement
2026
Apr 16
Board/Management Information
2026
Apr 10
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Regulatory Filings
2026
Mar 23
Board/Management Information
2026
Mar 4
Director's Dealing
2026
Mar 3
Capital/Financing Update
2026
Mar 2
Capital/Financing Update
2026
Feb 26